image
Healthcare - Medical - Devices - NYSE - US
$ 104.32
0.259 %
$ 20.8 B
Market Cap
23.55
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one ZBH stock under the worst case scenario is HIDDEN Compared to the current market price of 104 USD, Zimmer Biomet Holdings, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one ZBH stock under the base case scenario is HIDDEN Compared to the current market price of 104 USD, Zimmer Biomet Holdings, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one ZBH stock under the best case scenario is HIDDEN Compared to the current market price of 104 USD, Zimmer Biomet Holdings, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
2.02 B REVENUE
-72.64%
0 OPERATING INCOME
0.00%
1.02 B NET INCOME
251.65%
1.58 B OPERATING CASH FLOW
23.11%
-779 M INVESTING CASH FLOW
-47.18%
-764 M FINANCING CASH FLOW
9.52%
0 REVENUE
0.00%
0 OPERATING INCOME
0.00%
249 M NET INCOME
2.64%
396 M OPERATING CASH FLOW
7.12%
-155 M INVESTING CASH FLOW
37.29%
-102 M FINANCING CASH FLOW
-10.88%
Balance Sheet Zimmer Biomet Holdings, Inc.
image
Current Assets 4.61 B
Cash & Short-Term Investments 416 M
Receivables 1.44 B
Other Current Assets 2.75 B
Non-Current Assets 16.9 B
Long-Term Investments 31.6 M
PP&E 2.26 B
Other Non-Current Assets 14.6 B
Current Liabilities 2.86 B
Accounts Payable 411 M
Short-Term Debt 953 M
Other Current Liabilities 1.49 B
Non-Current Liabilities 6.15 B
Long-Term Debt 5.04 B
Other Non-Current Liabilities 1.11 B
EFFICIENCY
Earnings Waterfall Zimmer Biomet Holdings, Inc.
image
Revenue 2.02 B
Cost Of Revenue 744 M
Gross Profit 1.28 B
Operating Expenses 0
Operating Income 0
Other Expenses -1.02 B
Net Income 1.02 B
RATIOS
63.21% GROSS MARGIN
63.21%
0.00% OPERATING MARGIN
0.00%
0.00% NET MARGIN
0.00%
0.00% ROE
0.00%
0.00% ROA
0.00%
0.00% ROIC
0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Zimmer Biomet Holdings, Inc.
image
Net Income 1.02 B
Depreciation & Amortization 952 M
Capital Expenditures -603 M
Stock-Based Compensation 99.8 M
Change in Working Capital -396 M
Others -50 M
Free Cash Flow 1.2 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Zimmer Biomet Holdings, Inc.
image
Wall Street analysts predict an average 1-year price target for ZBH of $128 , with forecasts ranging from a low of $110 to a high of $150 .
ZBH Lowest Price Target Wall Street Target
110 USD 5.44%
ZBH Average Price Target Wall Street Target
128 USD 22.83%
ZBH Highest Price Target Wall Street Target
150 USD 43.79%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0.24 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Zimmer Biomet Holdings, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
1.47 M USD 1
9-12 MONTHS
216 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
9 months ago
May 31, 2024
Sell 1.47 M USD
Yi Sang
Group President, Asia Pacific
- 12857
114.691 USD
11 months ago
Mar 07, 2024
Sell 216 K USD
Yi Sang
Group President, Asia Pacific
- 1705
126.86 USD
1 year ago
Feb 22, 2024
Sell 3.29 M USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 25546
128.6067 USD
1 year ago
Feb 22, 2024
Sell 78.7 K USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 610
129.0807 USD
1 year ago
Nov 09, 2023
Bought 224 K USD
Jafry Syed A.
Director
+ 2135
104.75 USD
1 year ago
Aug 28, 2023
Bought 117 K USD
BEGLEY CHRISTOPHER B
Director
+ 1000
117.114 USD
1 year ago
Aug 30, 2023
Bought 120 K USD
Kolli Sreelakshmi
Director
+ 1000
120.37 USD
1 year ago
Aug 28, 2023
Bought 233 K USD
HAGEMANN ROBERT
Director
+ 2000
116.48 USD
1 year ago
Aug 25, 2023
Bought 150 K USD
MICHELSON MICHAEL W
Director
+ 1300
115.5 USD
1 year ago
Aug 25, 2023
Bought 100 K USD
BERNARD BETSY J
Director
+ 871
114.8364 USD
6 years ago
Mar 20, 2018
Bought 16.8 K USD
BERNARD BETSY J
Director
+ 150
111.8867 USD
1 year ago
Aug 23, 2023
Bought 57.3 K USD
HIGGINS ARTHUR J
Director
+ 500
114.6751 USD
1 year ago
Aug 23, 2023
Bought 58.3 K USD
HIGGINS ARTHUR J
Director
+ 500
116.55 USD
1 year ago
Mar 17, 2023
Sell 2.46 M USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 19743
124.402 USD
1 year ago
Mar 17, 2023
Sell 413 K USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 3302
125.089 USD
2 years ago
Dec 13, 2022
Sell 1.34 M USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 10459
128.5578 USD
2 years ago
Dec 13, 2022
Sell 137 K USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 1063
129.344 USD
2 years ago
Jul 01, 2022
Sell 55.9 K USD
VAN ZUILEN WILFRED
Pres, Europe, M. East & Africa
- 531
105.217 USD
2 years ago
Mar 17, 2022
Sell 3.6 M USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 29518
121.8996 USD
3 years ago
Dec 14, 2021
Sell 323 K USD
Yi Sang
President, Asia Pacific
- 2600
124.14 USD
3 years ago
Dec 14, 2021
Sell 24.8 K USD
Yi Sang
President, Asia Pacific
- 200
124.175 USD
3 years ago
May 06, 2021
Bought 172 K USD
HIGGINS ARTHUR J
Director
+ 1000
171.58 USD
4 years ago
Nov 18, 2020
Sell 183 K USD
Yi Sang
President, Asia Pacific
- 1200
152.59 USD
4 years ago
Nov 09, 2020
Sell 4.8 M USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 30040
159.7 USD
4 years ago
May 29, 2020
Sell 376 K USD
Yi Sang
President, Asia Pacific
- 3000
125.3767 USD
4 years ago
May 13, 2020
Bought 113 K USD
Hanson Bryan C
President and CEO
+ 1000
113 USD
5 years ago
Nov 11, 2019
Sell 445 K USD
Bruneau Aure
Group President
- 3150
141.306 USD
5 years ago
Nov 11, 2019
Sell 666 K USD
Bruneau Aure
Group President
- 4718
141.243 USD
5 years ago
Nov 11, 2019
Sell 228 K USD
Bruneau Aure
Group President
- 1613
141.475 USD
5 years ago
Nov 11, 2019
Sell 411 K USD
Bruneau Aure
Group President
- 2910
141.168 USD
5 years ago
Nov 11, 2019
Sell 392 K USD
Bruneau Aure
Group President
- 2780
141.14 USD
5 years ago
Sep 06, 2019
Sell 50.1 K USD
Deltort Didier
President, EMEA
- 360
139.25 USD
5 years ago
Sep 09, 2019
Sell 11.8 K USD
Deltort Didier
President, EMEA
- 84
140.42 USD
5 years ago
Aug 29, 2019
Sell 968 K USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 7000
138.276 USD
5 years ago
Aug 13, 2019
Sell 4.59 M USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 32800
140 USD
5 years ago
Aug 08, 2019
Sell 20.4 K USD
Yi Sang
President, Asia Pacific
- 147
138.695 USD
5 years ago
May 24, 2019
Sell 48.9 K USD
Yi Sang
President, Asia Pacific
- 426
114.878 USD
6 years ago
Mar 01, 2019
Bought 242 K USD
Jafry Syed A.
Director
+ 1925
125.5189 USD
6 years ago
Feb 15, 2019
Bought 61.6 K USD
HIGGINS ARTHUR J
Director
+ 500
123.2753 USD
6 years ago
Feb 13, 2019
Bought 247 K USD
Farrell Michael J.
Director
+ 2000
123.6248 USD
6 years ago
Feb 08, 2019
Bought 240 K USD
GLASSCOCK LARRY C
Director
+ 2000
120.091 USD
6 years ago
Feb 08, 2019
Bought 250 K USD
MICHELSON MICHAEL W
Director
+ 2085
119.6897 USD
6 years ago
Feb 07, 2019
Bought 195 K USD
Hilado Maria Teresa
Director
+ 1650
118.1759 USD
6 years ago
Feb 07, 2019
Bought 57.2 K USD
Hanson Bryan C
President and CEO
+ 480
119.1799 USD
6 years ago
Feb 07, 2019
Bought 133 K USD
Hanson Bryan C
President and CEO
+ 1120
119 USD
6 years ago
Feb 07, 2019
Bought 59.4 K USD
Hanson Bryan C
President and CEO
+ 500
118.8996 USD
6 years ago
Feb 05, 2019
Bought 250 K USD
BOUDREAUX GAIL
Director
+ 2095
119.326 USD
6 years ago
Feb 06, 2019
Bought 239 K USD
BEGLEY CHRISTOPHER B
Director
+ 2040
117.1909 USD
6 years ago
Feb 06, 2019
Bought 23.4 K USD
BEGLEY CHRISTOPHER B
Director
+ 200
117.1823 USD
6 years ago
Feb 06, 2019
Bought 23.4 K USD
BEGLEY CHRISTOPHER B
Director
+ 200
117.1786 USD
6 years ago
Feb 06, 2019
Bought 11.7 K USD
BEGLEY CHRISTOPHER B
Director
+ 100
117.1711 USD
6 years ago
Feb 06, 2019
Bought 11.7 K USD
BERNARD BETSY J
Director
+ 100
117.42 USD
6 years ago
Feb 06, 2019
Bought 487 K USD
BERNARD BETSY J
Director
+ 4150
117.41 USD
6 years ago
Feb 05, 2019
Bought 240 K USD
HAGEMANN ROBERT
Director
+ 2000
119.8256 USD
6 years ago
Sep 21, 2018
Sell 3.98 M USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 30100
132.368 USD
6 years ago
Aug 31, 2018
Bought 50.4 K USD
Hanson Bryan C
President and CEO
+ 410
123.03 USD
6 years ago
Jul 31, 2018
Sell 336 K USD
Collins Tony W.
VP, Controller and CAO
- 2670
125.7699 USD
6 years ago
Jul 31, 2018
Sell 13.6 K USD
Collins Tony W.
VP, Controller and CAO
- 108
125.745 USD
6 years ago
May 22, 2018
Sell 996 K USD
Mazur-Hofsaess Katarzyna
Pres., Eur., M. East & Afr.
- 8765
113.6104 USD
6 years ago
Apr 30, 2018
Sell 142 K USD
Collins Tony W.
VP, Controller and CAO
- 1213
116.7653 USD
6 years ago
Apr 30, 2018
Sell 13.6 K USD
Collins Tony W.
VP, Controller and CAO
- 117
116.32 USD
7 years ago
Feb 20, 2018
Bought 1.8 K USD
Hanson Bryan C
President and CEO
+ 15
119.859 USD
7 years ago
Feb 16, 2018
Bought 65.1 K USD
Hanson Bryan C
President and CEO
+ 545
119.3773 USD
7 years ago
Feb 15, 2018
Bought 1.43 M USD
Hanson Bryan C
President and CEO
+ 11915
119.7766 USD
7 years ago
Feb 15, 2018
Bought 1.51 M USD
Hanson Bryan C
President and CEO
+ 12602
119.6011 USD
7 years ago
Feb 12, 2018
Sell 1.44 M USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 12454
115.6365 USD
7 years ago
Feb 12, 2018
Sell 975 K USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 8372
116.4139 USD
7 years ago
Nov 29, 2017
Sell 731 K USD
Williamson Daniel E.
Group President
- 6282
116.2982 USD
7 years ago
Jul 31, 2017
Sell 1.84 M USD
Collins Tony W.
VP, Controller and CAO
- 15096
121.7095 USD
7 years ago
Jul 31, 2017
Sell 147 K USD
Collins Tony W.
VP, Controller and CAO
- 1200
122.3792 USD
7 years ago
Jul 31, 2017
Sell 11.3 K USD
Collins Tony W.
VP, Controller and CAO
- 93
121.7601 USD
7 years ago
Jul 31, 2017
Sell 72.4 K USD
Collins Tony W.
VP, Controller and CAO
- 597
121.32 USD
7 years ago
Jun 09, 2017
Sell 761 K USD
Yi Sang
President, Asia Pacific
- 6097
124.8599 USD
7 years ago
Jun 09, 2017
Sell 443 K USD
Yi Sang
President, Asia Pacific
- 3550
124.8614 USD
7 years ago
Jun 09, 2017
Sell 413 K USD
Yi Sang
President, Asia Pacific
- 3310
124.864 USD
7 years ago
Jun 09, 2017
Sell 59.2 K USD
Yi Sang
President, Asia Pacific
- 474
124.9301 USD
7 years ago
Jun 12, 2017
Sell 532 K USD
Yi Sang
President, Asia Pacific
- 4300
123.6157 USD
7 years ago
May 05, 2017
Sell 583 K USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 5000
116.6156 USD
7 years ago
May 05, 2017
Sell 141 K USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 1200
117.34 USD
7 years ago
Apr 27, 2017
Sell 6.13 M USD
DVORAK DAVID C
President and CEO
- 52784
116.13 USD
7 years ago
Apr 27, 2017
Sell 4.04 M USD
DVORAK DAVID C
President and CEO
- 34547
116.99 USD
7 years ago
Mar 20, 2017
Sell 126 K USD
DVORAK DAVID C
President and CEO
- 1040
121.63 USD
8 years ago
Feb 02, 2017
Sell 1.23 M USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 10500
117.6172 USD
8 years ago
Feb 02, 2017
Sell 5.22 M USD
Mazur-Hofsaess Katarzyna
Pres., Eur., M. East & Afr.
- 44195
118 USD
8 years ago
Feb 02, 2017
Sell 5.09 M USD
DVORAK DAVID C
President and CEO
- 43207
117.7717 USD
8 years ago
Dec 02, 2016
Sell 511 K USD
Nolan David A. Jr.
Group President
- 5050
101.1126 USD
8 years ago
Sep 08, 2016
Sell 353 K USD
Williamson Daniel E.
Group President
- 2716
129.9571 USD
8 years ago
Aug 23, 2016
Sell 441 K USD
Kleopfer Stuart G.
President, Americas
- 3397
129.7072 USD
8 years ago
Aug 12, 2016
Sell 116 K USD
Collins Tony W.
VP, Controller and CAO
- 900
128.96 USD
8 years ago
Aug 12, 2016
Sell 50.2 K USD
Collins Tony W.
VP, Controller and CAO
- 387
129.61 USD
8 years ago
Aug 09, 2016
Sell 70.7 K USD
Kleopfer Stuart G.
President, Americas
- 533
132.705 USD
8 years ago
Aug 01, 2016
Sell 1.87 M USD
Nolan David A. Jr.
Group President
- 14292
130.7279 USD
8 years ago
Aug 01, 2016
Sell 541 K USD
Nolan David A. Jr.
Group President
- 4138
130.7731 USD
8 years ago
Aug 01, 2016
Sell 893 K USD
Nolan David A. Jr.
Group President
- 6825
130.8468 USD
8 years ago
Jul 08, 2016
Sell 1.43 M USD
Florin Daniel P
Sr. VP, CFO
- 11432
124.98 USD
8 years ago
Jul 11, 2016
Sell 446 K USD
Florin Daniel P
Sr. VP, CFO
- 3568
124.98 USD
8 years ago
Jun 14, 2016
Sell 216 K USD
Collins Tony W.
VP, Controller and CAO
- 1858
116.3669 USD
8 years ago
Jun 14, 2016
Sell 204 K USD
Collins Tony W.
VP, Controller and CAO
- 1753
116.5003 USD
8 years ago
Jun 09, 2016
Sell 1.17 M USD
Williamson Daniel E.
Group President
- 9800
119.4819 USD
8 years ago
Jun 09, 2016
Sell 24 K USD
Williamson Daniel E.
Group President
- 200
120.05 USD
8 years ago
Jun 09, 2016
Sell 1.17 M USD
Kleopfer Stuart G.
President, Americas
- 9788
119.3861 USD
8 years ago
Jun 09, 2016
Sell 145 K USD
Kleopfer Stuart G.
President, Americas
- 1212
119.9703 USD
8 years ago
Apr 14, 2016
Sell 1.15 M USD
Florin Daniel P
Sr. VP, CFO
- 10000
114.98 USD
8 years ago
Apr 12, 2016
Sell 1.32 M USD
Florin Daniel P
Sr. VP, CFO
- 12000
110 USD
8 years ago
Mar 21, 2016
Sell 160 K USD
DVORAK DAVID C
President and CEO
- 1540
104.1579 USD
9 years ago
Feb 10, 2016
Sell 355 M USD
GOLDMAN SACHS GROUP INC
10 percent owner
- 3675850
96.66 USD
9 years ago
Feb 10, 2016
Sell 355 M USD
PRIVATE EQUITY PARTNERS 2004 DIRECT INVESTMENT FUND LP
10 percent owner
- 3675850
96.66 USD
9 years ago
Feb 10, 2016
Sell 148 M USD
BLACKSTONE CAPITAL PARTNERS V L P
10 percent owner
- 1538284
95.91 USD
9 years ago
Feb 10, 2016
Sell 148 M USD
Blackstone Group L.P.
10 percent owner
- 1538284
95.91 USD
9 years ago
Feb 09, 2016
Sell 196 USD
TPG Group Holdings (SBS) Advisors, Inc.
- 2.14
91.3701 USD
9 years ago
Jan 08, 2016
Sell 2.91 M USD
DVORAK DAVID C
President and CEO
- 28424
102.32 USD
9 years ago
Jan 08, 2016
Sell 1.67 M USD
DVORAK DAVID C
President and CEO
- 16237
102.71 USD
9 years ago
Dec 02, 2015
Sell 352 K USD
Nolan David A. Jr.
Group President
- 3435
102.6197 USD
9 years ago
Nov 16, 2015
Sell 77.8 K USD
Nolan David A. Jr.
Group President
- 742
104.8501 USD
9 years ago
Aug 07, 2015
Bought 192 K USD
HIGGINS ARTHUR J
Director
+ 1900
101 USD
9 years ago
Jun 29, 2015
Sell 5.22 K USD
Williamson Daniel E.
Group President
- 50
104.39 USD
9 years ago
Jun 29, 2015
Sell 8.13 K USD
Williamson Daniel E.
Group President
- 76
107 USD
9 years ago
Jun 29, 2015
Sell 2.7 K USD
Williamson Daniel E.
Group President
- 25
108 USD
9 years ago
Jun 29, 2015
Sell 214 K USD
Williamson Daniel E.
Group President
- 1955
109.4566 USD
9 years ago
Jun 29, 2015
Sell 576 K USD
Williamson Daniel E.
Group President
- 5207
110.5678 USD
9 years ago
Jun 29, 2015
Sell 743 K USD
Williamson Daniel E.
Group President
- 6673
111.3604 USD
9 years ago
Jun 29, 2015
Sell 167 K USD
Williamson Daniel E.
Group President
- 1489
112.306 USD
9 years ago
Jun 29, 2015
Sell 53.8 K USD
Williamson Daniel E.
Group President
- 475
113.3541 USD
9 years ago
Jun 29, 2015
Sell 5.7 K USD
Williamson Daniel E.
Group President
- 50
114.035 USD
9 years ago
Jun 29, 2015
Sell 5.22 K USD
Kleopfer Stuart G.
President, Americas
- 50
104.39 USD
9 years ago
Jun 29, 2015
Sell 8.13 K USD
Kleopfer Stuart G.
President, Americas
- 76
107 USD
9 years ago
Jun 29, 2015
Sell 2.7 K USD
Kleopfer Stuart G.
President, Americas
- 25
108 USD
9 years ago
Jun 29, 2015
Sell 214 K USD
Kleopfer Stuart G.
President, Americas
- 1955
109.4566 USD
9 years ago
Jun 29, 2015
Sell 436 K USD
Kleopfer Stuart G.
President, Americas
- 3945
110.5408 USD
9 years ago
Jun 29, 2015
Sell 596 K USD
Kleopfer Stuart G.
President, Americas
- 5356
111.3571 USD
9 years ago
Jun 29, 2015
Sell 131 K USD
Kleopfer Stuart G.
President, Americas
- 1163
112.3074 USD
9 years ago
Jun 29, 2015
Sell 43.1 K USD
Kleopfer Stuart G.
President, Americas
- 380
113.3321 USD
9 years ago
Jun 29, 2015
Sell 5.7 K USD
Kleopfer Stuart G.
President, Americas
- 50
114.035 USD
9 years ago
Jun 30, 2015
Sell 438 K USD
Kleopfer Stuart G.
President, Americas
- 4000
109.572 USD
9 years ago
Jun 30, 2015
Sell 110 K USD
Kleopfer Stuart G.
President, Americas
- 1000
110.3425 USD
9 years ago
Jun 29, 2015
Sell 10.2 K USD
Johnson Adam Rudolph
Group President
- 98
104.39 USD
9 years ago
Jun 29, 2015
Sell 15.8 K USD
Johnson Adam Rudolph
Group President
- 148
107 USD
9 years ago
Jun 29, 2015
Sell 5.29 K USD
Johnson Adam Rudolph
Group President
- 49
108 USD
9 years ago
Jun 29, 2015
Sell 416 K USD
Johnson Adam Rudolph
Group President
- 3800
109.4559 USD
9 years ago
Jun 29, 2015
Sell 407 K USD
Johnson Adam Rudolph
Group President
- 3687
110.4521 USD
9 years ago
Jun 29, 2015
Sell 690 K USD
Johnson Adam Rudolph
Group President
- 6193
111.3461 USD
9 years ago
Jun 29, 2015
Sell 122 K USD
Johnson Adam Rudolph
Group President
- 1084
112.3356 USD
9 years ago
Jun 29, 2015
Sell 50.2 K USD
Johnson Adam Rudolph
Group President
- 443
113.2637 USD
9 years ago
Jun 29, 2015
Sell 11.2 K USD
Johnson Adam Rudolph
Group President
- 98
114.035 USD
9 years ago
Jun 30, 2015
Sell 980 K USD
Johnson Adam Rudolph
Group President
- 8928
109.7552 USD
9 years ago
Jun 30, 2015
Sell 669 K USD
Johnson Adam Rudolph
Group President
- 6072
110.2223 USD
9 years ago
Jun 29, 2015
Sell 535 K USD
Florin Daniel P
Sr. VP, CFO
- 5000
107 USD
9 years ago
Mar 17, 2015
Sell 150 K USD
DVORAK DAVID C
President and CEO
- 1300
115.5522 USD
10 years ago
Dec 05, 2014
Sell 2.25 M USD
DVORAK DAVID C
President and CEO
- 19575
115 USD
10 years ago
Dec 05, 2014
Sell 3.35 M USD
DVORAK DAVID C
President and CEO
- 29128
115 USD
10 years ago
Nov 28, 2014
Sell 560 K USD
Phipps Chad F
Sr. VP/Gen Counsel/Secretary
- 5000
112.0015 USD
10 years ago
Nov 03, 2014
Sell 275 K USD
Mazur-Hofsaess Katarzyna
Pres., Eur., M. East & Afr.
- 2500
110.1265 USD
10 years ago
Nov 03, 2014
Sell 263 K USD
Mazur-Hofsaess Katarzyna
Pres., Eur., M. East & Afr.
- 2390
110.1257 USD
10 years ago
Nov 03, 2014
Sell 1.24 M USD
Mazur-Hofsaess Katarzyna
Pres., Eur., M. East & Afr.
- 11313
109.8778 USD
10 years ago
Nov 03, 2014
Sell 963 K USD
Mazur-Hofsaess Katarzyna
Pres., Eur., M. East & Afr.
- 8765
109.9138 USD
10 years ago
Nov 03, 2014
Sell 363 K USD
Mazur-Hofsaess Katarzyna
Pres., Eur., M. East & Afr.
- 3285
110.5835 USD
10 years ago
Sep 09, 2014
Sell 2.51 M USD
OOI STEPHEN HONG LIANG
President, Asia Pacific
- 24383
102.7788 USD
10 years ago
Sep 09, 2014
Sell 1.68 M USD
OOI STEPHEN HONG LIANG
President, Asia Pacific
- 16385
102.78 USD
10 years ago
Aug 26, 2014
Sell 1.65 M USD
CRINES JAMES T
EVP, Finance and CFO
- 16385
101 USD
7. News
ZBH Stock Hurt by Margin Concerns and Difficult Solvency Zimmer Biomet is suffering due to macroeconomic uncertainties, pricing pressure and unfavorable currency fluctuations. zacks.com - 2 weeks ago
Zimmer Biomet: Adding To The Growth Profile Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 drug overhang. The 2015 Zimmer Biomet merger hasn't been fully delivered, but recent organic growth and M&A actions are promising, with mid-single digit sales growth projected. The $1.2 billion Paragon 28 acquisition enhances foot and ankle orthopedics, despite short-term EPS dilution, and boosts Zimmer Biomet's growth profile. seekingalpha.com - 3 weeks ago
ZBH's Q4 Earnings Beat, Margins Contract, Stock Down in Premarket Zimmer Biomet benefits from its diversified portfolio outside of core orthopedics and the company's strategic investments in attractive, higher-growth segments. zacks.com - 3 weeks ago
Why Is Zimmer Biomet Stock Trading Lower On Thursday? On Thursday, Zimmer Biomet Holdings, Inc ZBH reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the Street estimates of $2.30. benzinga.com - 3 weeks ago
Zimmer Biomet Holdings, Inc. (ZBH) Q4 2024 Earnings Call Transcript Zimmer Biomet Holdings, Inc. (NYSE:ZBH ) Q4 2024 Earnings Conference Call February 6, 2025 8:30 AM ET Company Participants David DeMartino - Senior Vice President-Investor Relations Ivan Tornos - President and Chief Executive Officer Suketu Upadhyay - CFO and EVP, Finance, Operations and Supply Chain Conference Call Participants Robbie Marcus - JPMorgan Patrick Wood - Morgan Stanley Steven Lichtman - Oppenheimer and Company Matt Taylor - Jefferies David Roman - Goldman Sachs Vik Chopra - Wells Fargo Ryan Zimmerman - BTIG Danielle Antalffy - UBS Travis Steed - Bank of America Rick Wise - Stifel Matt Miksic - Barclays Jayson Bedford - Raymond James Operator Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, February 06, 2025. seekingalpha.com - 3 weeks ago
Zimmer (ZBH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Zimmer (ZBH) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 3 weeks ago
Zimmer Biomet forecasts 2025 profit below estimates Medical device maker Zimmer Biomet Holdings forecast full-year adjusted profit below Wall Street estimates on Thursday, as it anticipates a hit from a strong dollar. reuters.com - 3 weeks ago
Zimmer Biomet (ZBH) Surpasses Q4 Earnings and Revenue Estimates Zimmer Biomet (ZBH) came out with quarterly earnings of $2.31 per share, beating the Zacks Consensus Estimate of $2.30 per share. This compares to earnings of $2.20 per share a year ago. zacks.com - 3 weeks ago
Zimmer Biomet Announces Fourth Quarter and Full-Year 2024 Financial Results Fourth quarter net sales of $2.023 billion increased 4.3% and 4.9% on a constant currency1 basis Fourth quarter diluted earnings per share were $1.20; adjusted1 diluted earnings per share were $2.31 Full-year net sales of $7.679 billion increased 3.8% and 4.8% on a constant currency1 basis Full-year diluted earnings per share were $4.43; adjusted1 diluted earnings per share were $8.00 Company provides full-year 2025 financial guidance WARSAW, Ind. , Feb. 6, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2024. prnewswire.com - 3 weeks ago
Unveiling Zimmer (ZBH) Q4 Outlook: Wall Street Estimates for Key Metrics Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Zimmer (ZBH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024. zacks.com - 3 weeks ago
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Paragon 28, Inc. NEW YORK , Jan. 31, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. (NYSE: FNA) and its board of directors concerning the proposed acquisition of the company by Zimmer Biomet Holdings, Inc. (NYSE: ZBH). Stockholders will receive $13.00 and a contingent value right for up to $1.00 for each share of Paragon 28 stock that they hold. prnewswire.com - 1 month ago
Zimmer Biomet Set to Report Q4 Earnings: What's in Store? ZBH's Hips business is expected to have witnessed growth banking on its suite of navigation solutions in direct anterior stems and surgical impactors. zacks.com - 1 month ago
8. Profile Summary

Zimmer Biomet Holdings, Inc. ZBH

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 20.8 B
Dividend Yield 0.00%
Description Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Contact 345 East Main Street, Warsaw, IN, 46580 https://www.zimmerbiomet.com
IPO Date July 25, 2001
Employees 18000
Officers Mr. Chad F. Phipps J.D. Senior Vice President, General Counsel & Secretary Mr. Wilfred van Zuilen Group President of Europe, Middle East & Africa Ms. Angela Main Senior Vice President, Global Chief Compliance Officer & Associate General Counsel of Asia Pacific Mr. Paul A. Stellato Vice President, Controller & Chief Accounting Officer Mr. Suketu P. Upadhyay Chief Financial Officer and Executive Vice President of Finance, Operations & Supply Chain Ms. Rachel H. Ellingson Senior Vice President & Chief Administrative Officer Mr. Sang Yi President of Asia Pacific Mr. Ivan Tornos Chief Operating Officer, President, Chief Executive Officer & Director Mr. Shaun Braun Senior Vice President & Chief Information and Technology Officer Mr. David M. DeMartino Senior Vice President of Investor Relations